HALO

Halozyme Therapeutics Inc.

Halal Rating :
Uncomfortable
See Details
Last Price $45.67 Last updated:
Market Cap -
7D Change -25.11%
1 Year Change 15.56%

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Biological Products
  • Except Diagnostic Substances
Exchange
Next Earnings Date

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $290.08m $131.41m - $4.52m 0.00% 3.44%
June 30, 2024 $231.35m $118.64m - $4.52m 0.00% 3.81%
March 31, 2024 $195.88m $104.84m - $4.51m 0.00% 4.30%

Company Impact

Help us evaluate Halozyme Therapeutics Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates